title: American Society of Clinical Oncology identifies five key opportunities to improve care and reduce costs: the top five list for oncology.
authors.affiliation: Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA 02215, USA. lschnipp@bidmc.harvard.edu
authors.forename: Lowell E
authors.initials: LE
authors.lastname: Schnipper
authors.forename: Thomas J
authors.initials: TJ
authors.lastname: Smith
authors.forename: Derek
authors.initials: D
authors.lastname: Raghavan
authors.forename: Douglas W
authors.initials: DW
authors.lastname: Blayney
authors.forename: Patricia A
authors.initials: PA
authors.lastname: Ganz
authors.forename: Therese Marie
authors.initials: TM
authors.lastname: Mulvey
authors.forename: Dana S
authors.initials: DS
authors.lastname: Wollins
mesh_terms: D026683:Advisory Committees; D000970:Antineoplastic Agents / Q000191:economics / Q000627:therapeutic use; D003131:Combined Modality Therapy / Q000191:economics / Q000592:standards; D017046:Cost Savings; D003952:Diagnostic Imaging / Q000191:economics / Q000592:standards; D042241:Early Diagnosis; D005260:Female; D019983:Guideline Adherence; D006801:Humans; D008297:Male; D008495:Medical Oncology / Q000592:standards*; D009369:Neoplasms / Q000175:diagnosis* / Q000191:economics / Q000628:therapy*; D017410:Practice Guidelines as Topic; D011322:Primary Prevention / Q000191:economics / Q000592:standards; D058996:Quality Improvement; D018570:Risk Assessment; D012680:Sensitivity and Specificity; D012955:Societies, Medical / Q000592:standards
chemical_list: D000970:Antineoplastic Agents